Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 5/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17132510 | 0.94 | CYP11B1 (0.39) | CYP11B1CYP11B2GSK3BALDH1A1HPGD | |
| SCHEMBL21677461 | 0.94 | CYP11B1 (0.37) | CYP11B1CYP11B2IDO1TDO2LDHA | |
| SCHEMBL16485339 | 0.92 | CYP11B1 (0.41) | CYP11B1CYP11B2IDO1TDO2LDHA | |
| SCHEMBL17012320 | 0.91 | PIM1 (0.40) | CYP11B1CYP11B2DYRK1A | |
| SCHEMBL17012324 | 0.91 | TGFBR1 (0.36) | CYP11B1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL16485074 | 0.91 | CYP11B1 (0.35) | CYP11B1CYP11B2IDO1TDO2LDHA | |
| SCHEMBL17132508 | 0.88 | TGFBR1 (0.38) | CYP11B1TSHRMAPK1HSD17B10 | |
| SCHEMBL24416720 | 0.87 | CYP11B1 (0.39) | CYP11B1CYP11B2GSK3BALDH1A1HPGD | |
| SCHEMBL9888959 | 0.87 | CRHBP (0.42) | CRHBPCRHR2KEAP1NFE2L2METAP2 | |
| SCHEMBL16484666 | 0.86 | TGFBR1 (0.36) | TSHRMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2907803-B1 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | TORAY INDUSTRIES (JP) | 2021-08-18 | — | — | EP | disclosed |
| US-9935273-B2 | Fluoranthene derivative, light-emitting device material containing same, and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| EP-2907803-A1 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | Toray Industries, Inc. (JP) | 2015-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150280139-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE | FMNL1, AFF2, LEF1 | CYP11B1 4354/4885CYP11B2 3859/4885IDO1 2942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.